SophiaMatrix Training UG


SophiaMatrix Training UG
+49 8341 / 9664100


Your living room


Your living room
To the recordings


Mar 14 2021


All Day



Recording Theme day 3 (2021) – german

Seminar language: German

For patients, affected persons, therapists and interested parties

incl. access to the recordings of the day (approx. 6 hours) for 4 weeks.
incl. link to download the shown powerpoint

Seminar volume

approx. 6 hours


Registration possible at any time.

Access to the videos and link to Powerpoints will be sent via email afterwards.

For questions and registration please contact Pamela Lecher:

Either by email:
or by phone:  49 (0) 8341 966 4100

All ImmunSymbiosis courses are tax-exempt as educational services according to § 4 No. 21. a) bb) UStG!


  • The role of viruses in the context of ImmunSymbiosis.
    A new perspective on the complex and intelligent system of viruses and retroviruses. What immunomodulatory inputs do these antigens provide? Having gone through chickenpox infection significantly reduces the risk of developing gliomas, brain tumors. Living with children protects against shingles. These studies make a lot of sense in the context of ImmunSymbiosis. THE reason for chronic diseases lies in the absence of these inputs of the germs for the immune system.
    extrahepatic consequences of chronic hepatitis
  • Nanobacteria. Calcifying nanoparticles (CNPs) (nanobacteria, nanobacteria-like particles, nanobes) were discovered over 25 years ago; yet their nature is still unclear. Connections in neurodegenerative diseases, calcifications e.g. of arteries, cancer, multiple sclerosis, inflammation … The role of fetuin and the planning of new frequency chords.
  • Antiphospholipid syndrome, an autoimmune disorder affecting up to 5% of the population. It results in increased blood clotting and tendency to thrombosis. Mini-vascular occlusions in the brain can also result. One study shows an association between severe covid-19 courses and antiphospholipid syndrome. A frequency chord “antiphospholipid syndrome” is in progress.